COMMUNIQUÉS West-GlobeNewswire
-
Sharecare teams up with AWS to deliver health navigation through agentic, multi-model AI with AskMD
30/06/2026 -
Nelipak Healthcare Packaging receives ISCC PLUS certification for Clara, Ireland production facility
30/06/2026 -
Celebrate the Fourth—Without Damaging Your Hearing or Losing Your Voice
30/06/2026 -
SS Innovations Named Outstanding Company Winner at the 2026 Surgical Robotics Industry Awards
30/06/2026 -
FDA Selects Kyowa Kirin for PreCheck Pilot Program to Accelerate Manufacturing Timelines and Enhance Supply Chain Resilience
30/06/2026 -
Arcutis Launches New Virtual Health Platform Supporting Access to Care for Individuals Living with Chronic Inflammatory Skin Diseases, Including Approved ZORYVE® (roflumilast) Indications
30/06/2026 -
Psychemedics Releases 2026 Education Insights Report
30/06/2026 -
TPN.health Introduces Proprietary Integrated Claims and Credentialing Platform: Resolves Patient Barriers to Behavioral Health Access and Ensures Clinician Payments
30/06/2026 -
Cosmos Health Authorizes Up to $5 Million Share Repurchase Program
30/06/2026 -
ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel
30/06/2026 -
FEATOL Rolls Out Reinforced Lower Back Brace to Help Adults During Work, Driving, and in Chronic Pain
30/06/2026 -
Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer
30/06/2026 -
BellaSeno’s regenerative scaffolds signal new era for breast surgery
30/06/2026 -
HCW Biologics Regained Compliance with Bid Price Rule Per Nasdaq Compliance Letter
30/06/2026 -
Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board
30/06/2026 -
Candel Therapeutics Announces Initiation of Global Pivotal Phase 3 AURORA Trial Evaluating Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors
30/06/2026 -
Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program
30/06/2026 -
Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses
30/06/2026 -
Flare Therapeutics Secures $85M in Insider-Led Series C Financing and Appoints Anna Protopapas as Chief Executive Officer
30/06/2026
Pages